$ATRA Atara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual Congress Company to Host Live Conference Call and Webcast to Review Data Presentation on May 26, 2020 at 8:00 a.m. EDT/2:00 p.m. CEST Atara Resuming Enrollment in the Phase 1b Study After Brief COVID-19-Related Pause https://www.businesswire.com/news/home/20200519005372/en/Atara-Biotherapeutics-Present-Late-Breaking-ATA188-Data-Progressive Ждём 🚀